4H045 ペプチド又は蛋白質技術 Patent Trends
The Theme Code "ペプチド又は蛋白質技術" had 2,386 patent application filings in the publication-lag-adjusted comparison period (2024-01-01 to 2024-10-31). This is a with an decreasing trend transition of -295 filings (-11.0%) over 2,681 they had in the same period of the previous year (2023-01-01 to 2023-10-31).
The highest number of filings in 2021 with 4,587 cases, and their lowest number in 2024 with 2,458 cases (years covered: 2021, 2022, 2023, 2024).
The mean of the number of filings over the last 4 years (2021 to 2024, 14,140 cases in total) is 3,535, and the median is 3,548. The coefficient of variation (standard deviation/mean) is 0.22, and filings have been moderate fluctuations.
| Index | Value |
|---|---|
| Average | 3,535 patents |
| Std Dev | 774 |
| COV | 0.22 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 204 cases | -91.7% |
| 2024 year | 2,458 cases | -25.40% |
| 2023 year | 3,295 cases | -13.29% |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for ペプチド又は蛋白質技術[4H045] for the period of the last 6 years (2020 to 2025). You can compare the information in this report with the trends in your competitors’ patent filings and technologies.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of ペプチド又は蛋白質技術, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, and their top coapplicants (joint research partners, alliance partners). It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
ペプチド又は蛋白質技術, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of ペプチド又は蛋白質技術 over the last 6 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
ペプチド又は蛋白質技術 JP patent filing trend (unit: cases)
| Year | Cases |
|---|---|
| 2021 | 4,587 |
| 2022 | 3,800 |
| 2023 | 3,295 |
| 2024 | 2,458 |
| 2025 | 204 |
Patent Landscape
Patent landscaping is a visualization of the distribution of patent filings (application focus areas) for each technical keyword. Mountains and islands indicated by heatmap contours represent clusters of patent applications filed, and red areas on the heatmap indicate many patent filings relating to the keyword.
The patent landscape for ペプチド又は蛋白質技術 gives an intuitive understanding of what patent filings they have made and what technical position is to be established. By selecting filing year checkboxes and filtering, you can track their past filing trends (what technical area they have focused on).
By selecting applicant/patent holder checkboxes and filtering, you can visually grasp the technical areas of the filings for each applicant and the partnerships or alliances formed. Please use it as a guide for patent analysis and IP landscaping.
Keywords (importance)
Top keywords frequently used in patent filings for ペプチド又は蛋白質技術 are shown below.
Top keywords for ペプチド又は蛋白質技術
| Keyword | Score |
|---|---|
| 結合 | 100.0 |
| 抗体 | 98.27 |
| 組成 | 95.35 |
| 細胞 | 80.61 |
| 疾患 | 60.05 |
| 活性 | 56.39 |
| 配列 | 54.73 |
| 治療 | 51.67 |
| タンパク質 | 45.23 |
| 特異 | 41.87 |
| 修正 | 41.14 |
| 癌 | 36.78 |
| ヒト | 34.14 |
| 予防 | 31.41 |
| 発現 | 30.43 |
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 14,344 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
ペプチド又は蛋白質技術[4H045]
Recent publications
| Publication No. | Title | Bibliographic info | Theme |
|---|---|---|---|
| 1. JPA2026-174049 | 共重合体、コンジュゲート調製キット、エクソソーム回収キット、エクソソーム回収用コンジュゲートの製造方法、エクソソーム回収方法、エクソソーム回収用コンジュゲート、自動化装置、及び、分析システム | ・Applicant SPHINX株式会社, 国立研究開発法人物質・材料研究機構 ・Filing date 2025-04-18 ・Publication date 2026-10-29 | 2G045, 4B029, 4B065, 4H045, 4J100 |
| 2. JPA2026-174088 | 半月板再生用材料 | ・Applicant 三洋化成工業株式会社 ・Filing date 2025-04-18 ・Publication date 2026-10-29 | 4C084, 4H045 |
| 3. JPA-HYO2026-536110 | ボルテゾミブ、レナリドミド、及びデキサメタゾンと組み合わせた、抗ＣＤ３８抗体を含む、多発性骨髄腫を治療するための方法 | ・Applicant ヤンセンバイオテツクインコーポレーテツド ・Filing date 2024-10-11 ・Publication date 2026-10-29 | 4C076, 4H045 |
| 4. JPA-HYO2026-536120 | ＣＤ１９／ＣＤ２０を標的とする二重特異性キメラ抗原受容体及びその使用 本出願は、２０２３年１０月３日出願された米国仮特許出願第６３／５８７，６４６号の利益を主張するものであり、その開示内容は、あらゆる目的のためにその全体が参照により本明細書に援用される。 配列表 本出願には、本出願とともにＸＭＬファイルフォーマットで提出した電子配列表が含まれ、その全内容は、その全体が参照により本明細書に援用される。本出願とともに提出した配列表ＸＭＬファイルは、「１４１８３－０１６－２２８＿ＳＥＱＬＩＳＴＩＮＧ．ｘｍｌ」という名称であり、２０２４年９月３０日に作成され、７１，３２７バイトのサイズである。 | ・Applicant アタラバイオセラピューティクスインコーポレーテッド ・Filing date 2024-10-02 ・Publication date 2026-10-29 | 4B065, 4H045 |
| 5. JPA-HYO2026-536164 | 抗ＭＵＣ１＊抗体薬物複合体およびその使用 | ・Applicant ミネルババイオテクノロジーズコーポレーション ・Filing date 2024-10-09 ・Publication date 2026-10-29 | 4C076, 4H045 |
| 6. JPA-HYO2026-536197 | ＫＲＡＳ Ｇ１２Ｄ阻害剤およびＰＤ－１阻害剤またはＰＤ－Ｌ１阻害剤を使用する併用療法 | ・Applicant インサイトコーポレーション ・Filing date 2024-10-08 ・Publication date 2026-10-29 | 4H045 |
| 7. JPA-HYO2026-536217 | ヒトＤＬＬ３及びヒトＣＤ３に対する二重特異性抗体コンストラクトの組成物 | ・Applicant アムジェンインコーポレイテッド ・Filing date 2024-10-09 ・Publication date 2026-10-29 | 4H045 |
| 8. JPA-HYO2026-536248 | 抗体、コンジュゲート、およびそれらの使用 | ・Applicant アンティコアバイオファーマリミテッド ・Filing date 2024-10-11 ・Publication date 2026-10-29 | 4B064, 4C076, 4H045 |
| 9. JPA-HYO2026-536296 | 皮膚美白活性を有するペプチド及びその用途 | ・Applicant ケアジェンカンパニーリミテッド ・Filing date 2024-10-14 ・Publication date 2026-10-29 | 4H045 |
| 10. JPA-HYO2026-536306 | ナノボディ支援タンパク質又はポリペプチド発現システム並びにその製造及び使用方法 | ・Applicant 北京脳科学与類脳研究所 ・Filing date 2023-10-16 ・Publication date 2026-10-29 | 4B064, 4B065, 4H045 |
| 11. JPA-HYO2026-536310 | 悪性神経膠腫の治療のためのハイドロゲル組成物 | ・Applicant ターゲピューティクスインク ・Filing date 2024-10-14 ・Publication date 2026-10-29 | 4C076, 4H045 |
| 12. JPA-HYO2026-536331 | ＨＩＶ ＥＮＶ上のＶ３グリカン部位を標的とする広域中和抗体 | ・Applicant ウニヴェルジテート・ツー・ケルン ・Filing date 2024-10-14 ・Publication date 2026-10-29 | 4B064, 4B065, 4H045 |
| 13. JPA-HYO2026-536374 | 特異的ＴＩＧＩＴペプチド | ・Applicant 重慶精准生物技術有限公司, 重慶精准生物産業技術研究院有限公司 ・Filing date 2024-11-01 ・Publication date 2026-10-29 | 4B065, 4H045 |
| 14. JPA-HYO2026-536393 | 中心核ミオパチーの処置のためのアンチセンスオリゴマー | ・Applicant サレプタセラピューティクスインコーポレイテッド, マードックユニバーシティ ・Filing date 2024-10-18 ・Publication date 2026-10-29 | 4C076, 4H045 |
| 15. JPA-HYO2026-536412 | 舌下投与用のグルカゴン様ペプチド－１受容体作動薬ペプチドの医薬製剤 | ・Applicant イミュンワークインク ・Filing date 2025-01-17 ・Publication date 2026-10-29 | 4C076, 4H045 |
Same industry / competition company information (JP)
{'ja': '技術テーマ「ペプチド又は蛋白質技術」における上位出願人の特許情報を以下に示します。各企業の特許件数を比較することで、過去および現在の各社の技術テーマにおける研究開発状況や、技術テーマにおける各社の位置付けを確認できます。なお、特許は出願から公開までに一年半のタイムラグがあるため、一年半より直近の状況については分析できない点に注意する必要があります。', 'en': "The patent information of the higher applicant in the technical theme ペプチド又は蛋白質技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme. Patents have a time lag of about 18 months from filing to publication."}
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 106 cases, followed by イーライリリーアンドカンパニー with 62 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 106 cases |
| イーライリリーアンドカンパニー | 62 cases |
| ジェネンテックインコーポレイテッド | 52 cases |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 46 cases |
| ヤンセンバイオテツクインコーポレーテツド | 37 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 36 cases |
Trends in filing of joint patent applications for the target period (2020 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last for the target period (2020 to 2025) with 372 cases, followed by ジェネンテックインコーポレイテッド with 212 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 372 cases |
| ジェネンテックインコーポレイテッド | 212 cases |
| ヤンセンバイオテツクインコーポレーテツド | 210 cases |
| イーライリリーアンドカンパニー | 171 cases |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 151 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 144 cases |
Same industry / competition company JP patent filing ranking
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業の長期推移をどう読むか
同業や競合企業の長期的な特許出願件数の推移から、長期トレンドと出願件数の山や谷を確認することができます。
解説の続きを読む
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 6 companies in the same industry over the past 6 years.
Competitor filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 372 |
| ジェネンテックインコーポレイテッド | 212 |
| ヤンセンバイオテツクインコーポレーテツド | 210 |
| イーライリリーアンドカンパニー | 171 |
| エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 151 |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 144 |
Top company information (JP)
{'ja': '技術テーマ「ペプチド又は蛋白質技術」における上位出願人の特許情報を以下に示します。各企業の特許件数を比較することで、過去および現在の各社の技術テーマにおける研究開発状況や、技術テーマにおける各社の位置付けを確認できます。なお、特許は出願から公開までに一年半のタイムラグがあるため、一年半より直近の状況については分析できない点に注意する必要があります。', 'en': "The patent information of the higher applicant in the technical theme ペプチド又は蛋白質技術 is shown below. By comparing the number of patents of each company, you can check the research and development status of each company's past and present technical themes and the position of each company in the technical theme. Patents have a time lag of about 18 months from filing to publication."}
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業との比較のポイント
同業や競合企業が特許に注力している分野を知ることで、自社の戦略や製品開発の方向性を把握することができます。
解説の続きを読む
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 106 cases, followed by イーライリリーアンドカンパニー with 62 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 106 cases |
| イーライリリーアンドカンパニー | 62 cases |
| ジェネンテックインコーポレイテッド | 52 cases |
Trends in filing of joint patent applications for the target period (2020 to 2025).
among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last for the target period (2020 to 2025) with 372 cases, followed by ジェネンテックインコーポレイテッド with 212 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 372 cases |
| ジェネンテックインコーポレイテッド | 212 cases |
| イーライリリーアンドカンパニー | 171 cases |
Top company JP patent filing ranking
Below is a ranking of the number of JP patent applications by ペプチド又は蛋白質技術’s top 3 coapplicants over the last 6 years.
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業の長期推移をどう読むか
同業や競合企業の長期的な特許出願件数の推移から、長期トレンドと出願件数の山や谷を確認することができます。
解説の続きを読む
Top co-applicant filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 372 |
| ジェネンテックインコーポレイテッド | 212 |
| ヤンセンバイオテツクインコーポレーテツド | 210 |
Top company, Change in the Number of JP Patents
Below is a patent map showing the changes in the numbers of JP patent filings by ペプチド又は蛋白質技術’s top 3 coapplicants over the last 6 years.
Top co-applicant filing ranking
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 372 |
| ジェネンテックインコーポレイテッド | 212 |
| ヤンセンバイオテツクインコーポレーテツド | 210 |
Top company details
Trends in filing of joint patent applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド
ペプチド又は蛋白質技術 filed 372 joint applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 372 cases in total) is 74.4, and the median is 63.0. The coefficient of variation (standard deviation/mean) is 0.5, and filings have been large fluctuations.
Because some years show zero filings in the collected data, strong trend claims are avoided; see the yearly table. The highest number of filings in 2020 with 143 cases, and their lowest number in 2024 with 43 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 74.4 patents |
| Std Dev | 35.2 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 0 cases | -100% |
| 2024 year | 43 cases | -31.7% |
| 2023 year | 63 cases | +10.53% |
Trends in filing of joint patent applications with イーライリリーアンドカンパニー
ペプチド又は蛋白質技術 filed 171 joint applications with イーライリリーアンドカンパニー for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 162 cases in total) is 32.4, and the median is 33.0. The coefficient of variation (standard deviation/mean) is 0.19, and filings have been moderate fluctuations.
The highest number of filings in 2022 with 39 cases, and their lowest number in 2024 with 21 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 32.4 patents |
| Std Dev | 6.2 |
| COV | 0.19 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 9 cases | -57.1% |
| 2024 year | 21 cases | -34.4% |
| 2023 year | 32 cases | -17.95% |
Trends in filing of joint patent applications with ジェネンテックインコーポレイテッド
ペプチド又は蛋白質技術 filed 212 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2020 to 2025).
The mean of the number of filings over the last 5 years (2020 to 2024, 209 cases in total) is 41.8, and the median is 45.0. The coefficient of variation (standard deviation/mean) is 0.4, and filings have been large fluctuations.
The highest number of filings in 2021 with 65 cases, and their lowest number in 2024 with 18 cases (years covered: 2020, 2021, 2022, 2023, 2024).
| Index | Value |
|---|---|
| Average | 41.8 patents |
| Std Dev | 16.1 |
| COV | 0.4 |
| Year | Cases | YOY |
|---|---|---|
| 2025 year | 3 cases | -83.3% |
| 2024 year | 18 cases | -41.9% |
| 2023 year | 31 cases | -31.1% |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.
佐藤総合特許事務所 代表弁理士
佐藤 寿のコメント
競合企業との比較のポイント
同業や競合企業が特許に注力している分野を知ることで、自社の戦略や製品開発の方向性を把握することができます。
解説の続きを読む